Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.
about
Recent advances in the management of Hodgkin lymphomaProgressive multifocal leukoencephalopathy: current treatment options and future perspectivesCancer-treatment-induced neurotoxicity--focus on newer treatmentsProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Diagnostic, prognostic and therapeutic role of CD30 in lymphoma.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell TransplantationMelanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era.The evolving role of targeted drugs in the treatment of Hodgkin lymphoma.A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphoma.CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell Lymphomas.The confused oncologic patient: a rational clinical approach.Novel treatment concepts in Hodgkin lymphoma.Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system.Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.Current strategies for salvage treatment for relapsed classical Hodgkin lymphoma.Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions.Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results.Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome.Brentuximab vedotin: clinical updates and practical guidance.Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
P2860
Q26751214-37103B56-78B8-4E5F-83EA-3A33883254C1Q26776236-3DE721AD-4BDA-497D-BA07-72DCBB0474F1Q26782604-7C193D32-BD35-4950-99A1-9E201E5F8190Q30235523-7D73853D-B19D-44FF-90C2-467EFE31BCDEQ30239965-A2F4EC07-2E9A-4679-A9AB-B5896C54EC55Q30240160-4797F4B6-9B47-4C66-A8CB-324C0881F226Q30245002-21090E4D-2804-4B2F-AF1F-7545644909FDQ30815289-953D1F7B-39E2-47D3-9D57-442E8C3080FFQ33679931-18EA5F64-576D-419A-A1DA-1C10F7253F6BQ33891255-C1B15E60-5DE6-44E0-B66E-D4F9D9E3BD9FQ38361620-53BFAD1F-F8C1-41F7-AF6E-9D3A4AA680CEQ38700459-39A7087A-D906-47D8-8F84-15A626CDF05DQ38824046-FD5DAF8C-FD5B-4270-9815-4FBE8A608D35Q38950501-288935D0-2634-4BD2-82BB-ACE619006FC8Q38965811-42B5E696-756D-451E-A7B9-A1963794AB33Q39043082-3E448B54-CD95-4F17-A7BE-4CA96B1961C9Q39705818-046182C2-4836-4716-B2D8-8157599153BBQ41924854-88BA930E-6390-45CE-9CFC-A732CB47C2FFQ42155214-76093DEA-2B97-4A6C-9A4D-E3C3B840CC9FQ42375641-4F23B64A-F37C-4B6B-A86C-5092A3587479Q47102763-B241AA5C-E755-4A15-AA00-46D6466B118DQ47251529-7EF10C07-7E15-4067-95BD-B43988678992Q48296904-7A4012C8-BB3B-4BDA-A2A4-E13C058C4285Q49282959-6E49CFF4-C8CF-4A06-ADF8-4722D1704098Q55015964-8D0F11D8-39A6-401F-B528-EA9856C81514
P2860
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Progressive multifocal leukoen ...... rse Reactions (SONAR) project.
@ast
Progressive multifocal leukoen ...... rse Reactions (SONAR) project.
@en
type
label
Progressive multifocal leukoen ...... rse Reactions (SONAR) project.
@ast
Progressive multifocal leukoen ...... rse Reactions (SONAR) project.
@en
prefLabel
Progressive multifocal leukoen ...... rse Reactions (SONAR) project.
@ast
Progressive multifocal leukoen ...... rse Reactions (SONAR) project.
@en
P2093
P2860
P356
P1433
P1476
Progressive multifocal leukoen ...... rse Reactions (SONAR) project.
@en
P2093
Alain H Rook
Alison J Moskowitz
Alison W Loren
Charles L Bennett
Craig H Moskowitz
Daniel Landsburg
Dennis W Raisch
Donald Tsai
Ellen J Kim
Gloria von Geldern
P2860
P304
P356
10.1002/CNCR.28712
P407
P50
P577
2014-04-25T00:00:00Z